Mats Jerkeman

11 – 20 of 197

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/960ac58f-efc9-4246-b2b3-22c9226a529e?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
3
4
5
…
20
next »

2024
Mark CD163+ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression
de Matos Rodrigues, Joana ^LU ; Lokhande, Lavanya ^LU ; Olsson, Lina M ^LU ; Hassan, May ^LU ; Johansson, Angelica ^LU ; Janská, Anna ^LU ; Kumar, Darshan ; Schmidt, Lina ^LU ; Nikkarinen, Anna and Hollander, Peter , et al. (2024) In Blood Advances 8(16). p.4370-4385
- Contribution to journal › Article
Mark Body mass index and risk of over 100 cancer forms and subtypes in 4.1 million individuals in Sweden : the Obesity and Disease Development Sweden (ODDS) pooled cohort study
Sun, Ming ^LU ; da Silva, Marisa ^LU ; Bjørge, Tone ^LU ; Fritz, Josef ^LU ; Mboya, Innocent B ^LU ; Jerkeman, Mats ^LU ; Stattin, Pär ; Wahlström, Jens ; Michaëlsson, Karl and van Guelpen, Bethany , et al. (2024) In The Lancet regional health. Europe 45.
- Contribution to journal › Article
Mark Infections in patients with mantle cell lymphoma
Abalo, Kossi D. ; Ekberg, Sara ; Andersson, Therese M.L. ; Pahnke, Simon ; Albertsson-Lindblad, Alexandra ^LU ; Smedby, Karin E. ; Jerkeman, Mats ^LU and Glimelius, Ingrid (2024) In HemaSphere 8(7).
- Contribution to journal › Article
Mark The National Swedish Lymphoma Register – a systematic validation of data quality
Smedby, Karin E. ; Eloranta, Sandra ; Wästerlid, Tove ^LU ; Falini, Victor ^LU ; Jerlström, Urban ; Ellin, Fredrik ^LU ; Papworth, Karin ; Westerberg, Johanna ; Lewerin, Catharina and Andersson, Per Ola , et al. (2024) In Acta Oncologica 63. p.563-572
- Contribution to journal › Article
Mark Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy
Harrysson, Sara ; Eloranta, Sandra ; Ekberg, Sara ; Enblad, Gunilla ; Andersson, Per Ola ; Sonnevi, Kristina ; Ljungqvist, Maria ; Sander, Birgitta ; Jerkeman, Mats ^LU and Smedby, Karin E. (2024) In Leukemia and Lymphoma 65(4). p.534-537
- Contribution to journal › Letter
Mark ESMO Clinical Practice Guideline interim update on the use of targeted therapy in acute lymphoblastic leukaemia
Hoelzer, D. ; Bassan, R. ; Boissel, N. ; Roddie, C. ; Ribera, J. M. and Jerkeman, M. ^LU (2024) In Annals of Oncology 35(1). p.15-28
- Contribution to journal › Article
Mark Indirect treatment comparison of brexucabtagene autoleucel (ZUMA-2) versus standard of care (SCHOLAR-2) in relapsed/refractory mantle cell lymphoma
Hess, Georg ; Dreyling, Martin ; Oberic, Lucie ; Gine, Eva ; Zinzani, Pier Luigi ; Linton, Kim ; Vilmar, Adam ; Jerkeman, Mats ^LU ; Chen, Jenny M.H. and Ohler, Anke , et al. (2024) In Leukemia and Lymphoma 65(1). p.14-25
- Contribution to journal › Article
Mark Primary central nervous system lymphomas : EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Ferreri, Andreas J.M. ; Illerhaus, Gerald ; Doorduijn, Jeanette K. ; Auer, Dorothee P. ; Bromberg, Jacoline E.C. ; Calimeri, Teresa ; Cwynarski, Kate ; Fox, Christopher P. ; Hoang-Xuan, Khê and Malaise, Denis , et al. (2024) In HemaSphere 8(6).
- Contribution to journal › Article
Mark The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas
Bhansali, R.S. ; Relander, T. ^LU ; Jerkeman, M. ^LU and Barta, S.K. (2024) In Blood Advances 8(13). p.3507-3518
- Contribution to journal › Article
Mark Tattoos as a risk factor for malignant lymphoma: a population-based case–control study
Nielsen, Christel ^LU ; Jerkeman, Mats ^LU and Jöud, Anna ^LU (2024) In EClinicalMedicine 72.
- Contribution to journal › Article

« previous
1
2
3
4
5
…
20
next »